HRMY: Harmony Biosciences Holdings, Inc. Stock

by  •  • Comments Off on HRMY: Harmony Biosciences Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,602.24
Enterprise Value ($M) 1,328.50
Book Value ($M) 659.15
Book Value / Share 11.49
Price / Book 2.43
NCAV ($M) 239.21
NCAV / Share 4.17
Price / NCAV 6.70

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.17
Return on Equity (ROE) 0.28

Liquidity (mrq)
Quick Ratio 3.27
Current Ratio 3.31

Balance Sheet (mrq) ($M)
Current Assets 579.25
Assets 999.20
Liabilities 340.05
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 714.73
Operating Income 190.83
Net Income 145.49

Cash Flow Statement (mra) ($M)
Cash From Operations 219.82
Cash from Investing -67.48
Cash from Financing -11.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Valor IV Pharma Holdings, LLC 11.70 -40.83
02-10 13G/A Marshman Fund Trust II 10.60 -43.19
02-05 13G/A BlackRock, Inc. 12.20 16.09
01-30 13G/A Vanguard Group Inc 8.30 28.81

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 105,009 369,218 28.44
2025-04-16 227,401 680,512 33.42
2025-04-15 196,804 728,023 27.03
2025-04-14 59,307 291,485 20.35

(click for more detail)

Similar Companies
FULC – Fulcrum Therapeutics, Inc. GANX – Gain Therapeutics, Inc.
GHRS – GH Research PLC HROW – Harrow, Inc.
IKNA – Ikena Oncology, Inc.


Financial data and stock pages provided by
Fintel.io